D56.4 Hereditary persistence of fetal hemoglobin [HPFH]

Name of the Condition

• Hereditary persistence of fetal hemoglobin [HPFH]

Summary

Hereditary persistence of fetal hemoglobin (HPFH) is a genetic condition characterized by the continued production of fetal hemoglobin (HbF) into adulthood. Fetal hemoglobin is typically replaced by adult hemoglobin (HbA) after birth, but in HPFH, elevated levels of HbF persist. This condition is generally benign and often asymptomatic, as HbF can effectively carry oxygen. The elevated HbF levels are due to genetic mutations that disrupt the normal switch from fetal to adult hemoglobin production.

Causes

HPFH is caused by inherited genetic mutations that affect the regulation of hemoglobin synthesis. These mutations typically occur in the genes controlling the switch from fetal to adult hemoglobin, such as the HBB gene cluster or regulatory regions. The condition is inherited in an autosomal dominant or recessive pattern, depending on the specific mutation. Unlike thalassemia, HPFH does not involve reduced hemoglobin production but rather altered hemoglobin composition.

Risk Factors

• Family history of HPFH or related hemoglobin disorders
• Ethnic background (more common in certain populations, such as individuals of African, Mediterranean, or Southeast Asian descent)
• Consanguineous relationships

Symptoms

• Often asymptomatic; may be detected incidentally during blood tests
• Mild anemia in rare cases
• No specific symptoms directly attributable to HPFH in most individuals

Diagnosis

Diagnosis involves blood tests to measure hemoglobin levels and identify the presence of elevated HbF. Hemoglobin electrophoresis or high-performance liquid chromatography (HPLC) can confirm increased HbF levels. Genetic testing may be used to identify specific mutations associated with HPFH. The condition is often diagnosed incidentally during evaluations for other hemoglobin disorders.

Treatment Options

• No specific treatment is required for HPFH, as it is typically benign.
• Management focuses on monitoring and addressing any unrelated symptoms or conditions.
• In rare cases where anemia occurs, supportive care may be provided.

Prognosis and Follow-Up

The prognosis for HPFH is excellent, as the condition is generally asymptomatic and does not lead to complications. Follow-up is typically unnecessary unless other hemoglobin disorders are present. Regular monitoring is not required for individuals with isolated HPFH.

Complications

• Generally none; HPFH is not associated with significant health risks.
• Rarely, may coexist with other hemoglobinopathies, which could complicate management.

Lifestyle & Prevention

• No specific lifestyle modifications are needed for HPFH.
• Genetic counseling may be recommended for individuals with a family history to understand inheritance patterns.

When to Seek Professional Help

• If symptoms such as unexplained fatigue or anemia develop, consult a healthcare provider.
• Seek medical advice if HPFH is diagnosed incidentally and there are concerns about related conditions.

Tips for Medical Coders

When coding for hereditary persistence of fetal hemoglobin (HPFH), use the ICD-10-CM code D56.4. Ensure documentation supports the diagnosis, including laboratory results showing elevated fetal hemoglobin levels and genetic testing if performed. Note that HPFH is distinct from other hemoglobin disorders and should not be confused with thalassemia or sickle cell disease. Verify that the code is assigned based on confirmed clinical and laboratory findings.